Pregnancy and chronic headache

Expert Opinion on Pharmacotherapy

Volumn 3, Issue 4, 2002, Pages 389-393

  Marcus, Dawn A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Headache; Migraine; Pregnancy

Indexed keywords

AMFEBUTAMONE; ANALGESIC AGENT; ANTIDEPRESSANT AGENT; ANTIEMETIC AGENT; ANTIMIGRAINE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CODEINE; DIPHENHYDRAMINE; ESTROGEN; FLUNARIZINE; GABAPENTIN; METOCLOPRAMIDE; NARATRIPTAN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; PROCHLORPERAZINE; PROMETHAZINE; PROSTAGLANDIN; SEROTONIN UPTAKE INHIBITOR; SUMATRIPTAN; TRICYCLIC ANTIDEPRESSANT AGENT; TYRAMINE; VALPROIC ACID;

CHRONIC DISEASE; CONTROLLED STUDY; DIET THERAPY; DRUG EFFICACY; DRUG SAFETY; ESTROGEN BLOOD LEVEL; FEEDBACK SYSTEM; FEMALE; FIRST TRIMESTER PREGNANCY; HEADACHE; HORMONE ACTION; HORMONE DETERMINATION; HUMAN; LEISURE; LOW BIRTH WEIGHT; MATERNAL DISEASE; MIGRAINE; PATHOGENESIS; RELAXATION TRAINING; REVIEW; TERATOGENICITY; TREATMENT PLANNING; ANIMAL; HEADACHE AND FACIAL PAIN; PATHOPHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; PSYCHOLOGICAL ASPECT;

ANIMALS; FEMALE; HEADACHE DISORDERS; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 0036242142     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.3.4.389     Document Type: Review

References (62)

1. Migraine in the United States: A review of epidemiology and health care use
2. Epidemiology of tension-type headache
3. Interrelationships of neurochemicals, estrogen, and recurring headache
4. Sex hormones and chronic headache in women
5. The migraine syndrome in pregnancy
6. Migraine without aura and reproductive life events: A clinical epidemiological study in 1300 women
7. Headache recurrences in pregnant women with migraine
8. Primary headaches and pregnancy
9. Migraine and tension-type headache in a general population: Precipitating factors, female hormones, sleep patterns and relation to life
10. Longitudinal prospective study of headache during pregnancy and postpartum
11. Headaches in the first post partum week and their relationship to migraine
12. Headaches after childbirth
13. Breastfeeding and migraine headaches
14. Depressive symptomatology during pregnancy: Evidence for an association with decreased fetal growth in pregnancy of lower social class women
15. Nonpharmacologic treatment of migraine
16. Menstrual migraine headache: Results of a controlled, experimental, outcome study of non-drug treatments
17. The differential effects of biofeedback in the treatment of menstrual and nonmenstrual migraine
18. Impact of cigarette smoking on headache activity in headache patients
19. Relaxation therapy in migraine and chronic tension headache
20. Biofeedback applications to migraine and tension headache: A double-blinded outcome study
21. The efficacy and cost-effectiveness of minimal-therapist-contact, non-drug treatments of chronic migraine and tension headache
22. Nonpharmacological treatment for migraine: Incremental utility of physical therapy with relaxation and thermal biofeedback
23. Nonpharmacologic management of headaches during pregnancy
24. Maintenance of effects in the nonmedical treatment of headaches during pregnancy
25. Mass fragmentography of phenylethylamine, m- and p-tyramine and related amines in plasma, cerebrospinal fluid, urine, and brain
26. Dietary factors in migraine precipitation: The physician's view
27. Variations in food preference and consumption across the menstrual cycle
28. Chocolate craving and liking
29. Headache triggers and coping responses of different diagnostic groups
30. Brain serotonin, carbohydrate-craving, obesity and depression
31. The role of diet in migraine
32. A double-blind provocative study of chocolate as a trigger for headache
33. The effect of aspartame on migraine headache
34. Long-term prognosis of analgesic withdrawal in patients with drug-induced headache
35. Effect of diclofenac on implantation and embryonic development in the rat
36. Inhibitory effects of indomethacin on implantation and its related phenomena
37. Constriction of fetal ductus arteriosus by non-steroidal anti-inflammatory drugs: Study of additional 34 drugs
38. Contraction of the fetal ductus arteriosus induced by diclofenac. Case report
39. Severe pulmonary hypertension in a neonate caused by premature closure of the ductus arteriosus following maternal treatment with diclofenac: A case report
40. Exposure to prescribed drugs in pregnancy and association with congenital malformations
41. Association between oral cleft and drugs taken during pregnancy
42. Epidemiology of cleft lip and palate: An attempt to rule out chance correlations
43. Drug use and dependence
44. Intramuscular prochlorperazine versus metoclopramide as single-agent therapy for the treatment of acute migraine headache
45. Randomized, placebo-controlled evaluation of prochlorperazine versus metochlorpramide for emergency department treatment of migraine headache
46. Pregnancy outcome following first trimester exposure to sumatriptan
47. Pregnancy and perinatal outcomes in migraineurs using sumatriptan: A prospective study
48. Pregnancy outcome following prescription for sumatriptan
49. Delivery outcome in women who used drugs for migraine during pregnancy with special reference to sumatriptan
50. A comparative study of amitriptyline and fluvoxamine in migraine prophylaxis
51. Paroxetine as migraine prophylaxis
52. Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: A prospective controlled multicenter study
53. Fluoxetine for migraine prophylaxis: A double-blind study
54. A comparative efficiency of amitriptyline, fluoxetine, and maprotiline in prevention of migraine in attack-free period
55. Treatment of headache with bupropion
56. Potentially safe and effective new treatment for migraine?
57. Pregnancy in women with epilepsy: Preliminary results of Kerala registry of epilepsy and pregnancy
58. Effects of prenatal exposure to tricyclic antidepressants on adrenergic responses in progeny
59. Calcium channel blockers for potential impaired fetal growth
60. The risk of limb deficiencies and other congential abnormalities in children exposed in utero to calcium channel blockers
61. Epidemiology and socio-economic impact of headache
62. Identification of patients with headache at risk of psychological distress